We've been developing the treatments, seeing the amazing results in trial and then we hit this roadblock... So we needed to find a way to get it to patients.
The move comes amid concern about the affordability of gene therapies...these treatments don't literally cost 1m and could cost one-tenth of this under the approach Gosh is hoping to pioneer.
[
add
]
[
|
|
...
]